Melinta Therapeutics Revenue 2010-2019 | MLNT

Melinta Therapeutics revenue from 2010 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Melinta Therapeutics Annual Revenue
(Millions of US $)
2018 $96
2017 $34
2016 $
2015 $
2014 $15
2013 $8
2012 $
2011 $
2010 $
2009 $
Melinta Therapeutics Quarterly Revenue
(Millions of US $)
Q2 2019 $16
Q1 2019 $14
Q4 2018 $35
Q3 2018 $34
Q2 2018 $12
Q1 2018 $15
Q4 2017 $4
Q3 2017 $3
Q2 2017 $4
Q1 2017 $22
Q4 2016
Q3 2016 $4
Q2 2016 $3
Q1 2016 $3
Q4 2015
Q3 2015 $2
Q2 2015 $5
Q1 2015 $14
Q4 2014 $2
Q3 2014 $8
Q2 2014 $2
Q1 2014 $3
Q4 2013 $2
Q3 2013 $1
Q2 2013 $5
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q4 2009
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.040B $0.096B
Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide new and better therapeutic solutions. Melinta's lead product is Baxdela, an antibiotic approved by the US FDA for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). Melinta also has an extensive pipeline of preclinical and clinical stage products that were developed internally or assumed under the 2017 acquisition of Cempra, Inc. This pipeline includes many important classes of antibiotics, each targeted at a different segment of the anti-infective market. Melinta is headquartered in New Haven, CT.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $57.794B 35.59
Astellas Pharma (ALPMY) Japan $28.552B 14.00
Takeda Pharmaceutical (TAK) Japan $27.154B 8.48
Eisai (ESALY) Japan $14.621B 25.14
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.113B 19.26
Grifols, S.A (GRFS) Spain $13.964B 17.82
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Ionis Pharmaceuticals (IONS) United States $9.301B 20.06
Neurocrine Biosciences (NBIX) United States $8.829B 0.00
IPSEN SA ADR (IPSEY) France $8.399B 0.00
Sage Therapeutics (SAGE) United States $8.254B 0.00
Catalent (CTLT) United States $7.498B 29.68
Jazz Pharmaceuticals (JAZZ) Ireland $7.441B 9.79
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.025B 18.07
FibroGen (FGEN) United States $3.606B 90.20
United Therapeutics (UTHR) United States $3.538B 0.00
Nektar Therapeutics (NKTR) United States $3.525B 0.00
Evotec AG (EVTCY) Germany $3.369B 46.12
Taro Pharmaceutical Industries (TARO) Israel $3.144B 11.27
Tilray (TLRY) Canada $3.090B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.840B 65.11
PTC Therapeutics (PTCT) United States $2.527B 0.00
Portola Pharmaceuticals (PTLA) United States $2.096B 0.00
Xencor (XNCR) United States $2.003B 43.68
Zogenix (ZGNX) United States $1.842B 0.00
Heron Therapeutics (HRTX) United States $1.637B 0.00
USANA Health Sciences (USNA) United States $1.596B 16.01
Pacira Pharmaceuticals (PCRX) United States $1.588B 57.80
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.517B 20.84
Ironwood Pharmaceuticals (IRWD) United States $1.502B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.338B 22.07
Radius Health (RDUS) United States $1.307B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.299B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.044B 4.65
Aerie Pharmaceuticals (AERI) United States $1.015B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.000B 0.00
ArQule (ARQL) United States $0.958B 0.00
Endo (ENDP) Ireland $0.878B 1.55
TherapeuticsMD (TXMD) United States $0.825B 0.00
Concordia (CXRXF) Canada $0.770B 0.00
Karyopharm Therapeutics (KPTI) United States $0.683B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.640B 0.00
Akebia Therapeutics (AKBA) United States $0.606B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.605B 0.00
Organogenesis Holdings (ORGO) United States $0.569B 0.00
Lannett Co Inc (LCI) United States $0.564B 5.94
Translate Bio (TBIO) United States $0.540B 0.00
Flexion Therapeutics (FLXN) United States $0.533B 0.00
Dermira (DERM) United States $0.487B 0.00
Indivior (INVVY) United States $0.482B 1.74
Aptorum Group (APM) China $0.477B 0.00
ImmunoGen (IMGN) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.462B 1.08
Dova Pharmaceuticals (DOVA) United States $0.461B 0.00
Innate Pharma SA (IPHYF) France $0.444B 0.00
ChemoCentryx (CCXI) United States $0.440B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
Crinetics Pharmaceuticals (CRNX) United States $0.413B 0.00
Harpoon Therapeutics (HARP) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.400B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.371B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.340B 0.00
DURECT (DRRX) United States $0.336B 0.00
Ardelyx (ARDX) United States $0.333B 0.00
CV Sciences (CVSI) United States $0.310B 0.00
OptiNose (OPTN) United States $0.298B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.296B 0.00
Rafael Holdings (RFL) United States $0.290B 0.00
Xeris Pharmaceuticals (XERS) United States $0.281B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.277B 0.00
KalVista Pharmaceuticals (KALV) United States $0.272B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.269B 0.00
Recro Pharma (REPH) United States $0.269B 0.00
Concert Pharmaceuticals (CNCE) United States $0.255B 0.00
Molecular Templates (MTEM) United States $0.232B 0.00
CannTrust Holdings (CTST) Canada $0.228B 0.00
Calithera Biosciences (CALA) United States $0.225B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.200B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 32.29
Redhill Biopharma (RDHL) Israel $0.168B 0.00
Generex Biotechnology (GNBT) United States $0.167B 0.00
Taiwan Liposome (TLC) Taiwan $0.159B 0.00
IMV INC (IMV) Canada $0.156B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.147B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Cardiome Pharma (CORV) Canada $0.139B 0.00
Majesco Entertainment (PTE) United States $0.118B 0.00
Jounce Therapeutics (JNCE) United States $0.116B 0.00
ElectroCore (ECOR) United States $0.111B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.110B 0.00
Mast Therapeutics (SVRA) United States $0.109B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.096B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.088B 0.00
Iterum Therapeutics (ITRM) Ireland $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Aquestive Therapeutics (AQST) United States $0.085B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
RENEURON GP (RNUGF) United Kingdom $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 29.82
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.075B 7.48
Lipocine (LPCN) United States $0.074B 0.00
Novan (NOVN) United States $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.070B 605.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.066B 0.00
Jaguar Animal Health (JAGX) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
China SXT Pharmaceuticals (SXTC) China $0.061B 0.00
Capnia (SLNO) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.055B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.052B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.045B 1.56
India Globalization Capital (IGC) United States $0.045B 0.00
Aclaris Therapeutics (ACRS) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
PharmAthene (ALT) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Vical (BBI) United States $0.015B 0.00
Shineco (TYHT) China $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00